PIK3CA and cholangiocarcinoma: For this purpose, we analyzed a collection of human HCC (n=54), CCA (n=42), and mixed HCC/CCA (n=16) by immunohistochemistry for PIK3CA and Yap staining (Figures 6 and 7).